+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
From
From
Systemic Lupus Erythematosus - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 240 Pages
  • Global
From
US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 - Product Thumbnail Image

US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029

  • Report
  • September 2023
  • 230 Pages
  • United States
From
Chronic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Ankylosing Spondylitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
From
From
From
Respiratory Drug Delivery Market Report 2024-2034 - Product Thumbnail Image

Respiratory Drug Delivery Market Report 2024-2034

  • Report
  • January 2024
  • 348 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024 - Product Thumbnail Image

Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Ulcerative Colitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Loading Indicator